Introduction Accurate imaging is essential for staging prostate cancer and guiding
management decisions. Conventional imaging modalities are hampered by a limited …

Metastatic tumor deposits in bone marrow elicit differential bone responses that vary with the
type of malignancy. This results in either sclerotic, lytic, or mixed bone lesions, which can …

Purpose Prostate-specific membrane antigen (PSMA) positron emission tomography
(PET)/computed tomography (CT) is used for (re) staging prostate cancer (PCa) and as a …

We aimed to evaluate the role of PET targeting the prostate-specific membrane antigen
(PSMA) for response assessment in metastatic prostate cancer (PCa) patients treated with …

Quantitative evaluation of prostate-specific membrane antigen (PSMA)–targeting PET/CT
remains challenging but is urgently needed for the use of standardized PET-based response …

Simple Summary The huge armamentarium of currently available theragnostic modalities
allows a novel approach to prostate cancer from imaging to therapy. Clinical examination is …

Prostate-specific membrane antigen (PSMA)-directed positron emission tomography (PET)
has gained increasing interest for imaging of men affected by prostate cancer (PC). In recent …

Simple Summary Prostate-specific membrane antigen (PSMA)-targeted PET/CT imaging is
increasingly being used for (re) staging in prostate cancer. Although PSMA suggests …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis,
mainly due to difficulty in early detection of the disease by current imaging modalities. In this …

Objectives PET‐based radiomic metrics are increasingly utilized as predictive image
biomarkers. However, the repeatability of radiomic features on PET has not been assessed …